The biotech sector, tracked by iShares Biotechnology ETF, rallied 40% in six months on rising M&A activity, still below ...

Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. M&A activity is ...

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and rose 73.06% from its 52-week low price of $66.66/share. But, are ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

Biopharma has finally begun catching up with the overall stock market, as shares of the top three biopharma exchange traded funds (ETFs) jumped well into double digits over the past six months.

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). Year to ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an ...

Cathie Wood's ARK Invest sold $50.2 million in Pinterest stock while buying $6.19 million in Bitmine and over $8 million in ...

This rally in Illumina proved a shot in the arm for one of the most Illumina-sensitive funds, the ARK Genomic Revolution ETF (BATS:ARKG). It surged about 4% this week to outperform broader biotech ...

Global drug stocks rally as the FDA names Richard Pazdur, its top cancer drug regulator, as the head of its influential ...

LifeSci Partners, LLC launched two new ETFs that concentrate on one of the most popular sectors in the market. The New York-based investment advisor launched the BioShares Biotechnology Clinical ...